Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry

Published by: Datamonitor

Published: Jul. 20, 2007 - 111 Pages


Table of Contents



CHAPTER 1 EXECUTIVE SUMMARY

Scope of the report

Key findings

CHAPTER 2 INTRODUCTION TO PATIENT EMPOWERMENT

What is patient power?

How patient power is measured

Factors influencing patient empowerment

Increased access to information

Healthcare systems: US versus EU

Differences in patient empowerment between the US and the EU

The nature of the disease

The changing patient-physician relationship

How do these factors influence patient empowerment

Overall trends in patient power

CHAPTER 3 PATIENT ADVOCACY GROUPS

What are patient advocacy groups and what do they do?

Patient education

Support for patients and caregivers

Fundraising

Lobbying

Patient representatives sit on boards of decision-making bodies

Characteristics of successful of PAGs

Empowered patients can change healthcare outcomes

Equal access to drugs

Influence on reimbursement of expensive drugs

More efficient clinical trial recruitment and design

Faster approval times for drugs

Increased funding for research

Improved patient compliance

Empowered patients can lead to increased prescription rates and sales

Empowered patients can change healthcare outcomes in a way that is beneficial for both patients and drug producers

Case studies — outcomes beneficial for patients and the pharmaceutical industry

Activities of patient advocacy groups can have a negative impact on pharmaceutical companies

Threats — lowering drug prices

Case studies of damaging relationship with PAGs

Negative publicity can damage the reputation and public perception of pharmaceutical companies but can also impact sales

Working with patient advocacy groups - how to achieve a win-win situation

Effective communication and exchange of information is crucial

Co-ordinating activities

Nurturing the relationship

Sponsorship

Advantages of a patient-centric approach

The relationship between PAGs and pharmaceutical companies is under increased scrutiny

Communication with PAGs can improve company’s public image with the patients

Ideal PAG partner for collaboration with pharmaceutical companies

CHAPTER 4 MARKETING STRATEGIES IN A PATIENT-FOCUSED AGE

Shift towards consumer-focused healthcare

The internet as a marketing channel

DTC advertising

Not all therapy areas are suitable for DTC advertising

Brand versus disease awareness

Communication of medical information through PAGs is the only route for disseminating drug specific information in Europe

CHAPTER 5 THE FUTURE OF PATIENT EMPOWERMENT

Drivers and resistors of patient empowerment in the future

Patients’ desire to inform themselves and the availability of information through internet will continue to drive patient power

The aging population

Information overload - quality marks are needed

The cost-containment pressure contributes to rising patient power

Direct-to-consumer advertising - any changes ahead?

Relationship between PAGs and the pharmaceutical industry will be closely watched

Cases to watch

Avastin and Erbitux are not approved for colorectal cancer

Court challenge for NICE’s ruling over acetylcholine esterase inhibitors for mild

Alzheimer’s disease

NICE has blocked Macugen, and Lucentis is approved with restrictions

FDA’s decision not to approve prostate cancer drug Provenge angered patients

Patients are voicing their opinions regarding the legislation surrounding biosimilars

Consolidation of PAGs

Consolidation and collaboration have advantages but also challenges

CHAPTER 6 BIBLIOGRAPHY

Publications and online articles

Datamonitor resources

Websites

GLOSSARY




LIST OF FIGURES




Figure 1: Drivers and resistors of patient empowerment

Figure 2: Internet penetration in the seven major markets

Figure 3: Disease characteristics influence the level of patient empowerment

Figure 4: Trends in patient power

Figure 5: Characteristics of a successful patient advocacy group

Figure 6: Empowered patients can change healthcare outcomes

Figure 7: Attributes of an ideal patient advocacy group for partnering with pharmaceutical companies

Figure 8: Drivers and resistors of patient power in the future

Abstract

Introduction

Datamonitor has identified the key trends and events that drive patient empowerment and impact the pharmaceutical industry. These range from the increased access to information via internet and the rising pressures of cost containment through to how patient empowerment is affecting access to drugs as well as changing pharmaceutical marketing strategies and their public image.

Scope

Overview of the key trends driving patient empowerment Overview of how empowered patients and patient advocacy groups can change healthcare outcomes including case studies Analysis of the marketing strategies that companies are using to address the rise in patient education and harness patient power Identification of future trends shaping evolution of patient empowerment

Highlights

Increased access to the internet, the rising pressures of cost containment and the changing patient-physician relationship are the key factors driving the rise in patient empowerment. Disease characteristics are one of the key factors determining how powerful different patient groups are. Empowered patients can influence most healthcare outcomes: access to drugs, reimbursement policies, approval of new drugs, clinical trial recruitment, patient compliance and prescription rates. However they can also lead to reduction in drug prices and negative publicity for the pharmaceutical industry. Pharmaceutical companies are investing effort into harnessing patient power through working with patient advocacy groups. Legal restrictions and increased public scrutiny are limiting how companies can work with patient groups and communication of medical information is the main form of contact in Europe.

Reasons to Purchase

Identify the key trends that are driving a rise in patient empowerment Understand how patient advocacy groups can affect the pharmaceutical industry Gain insight into how pharmaceutical companies are working with patient advocacy groups and how marketing strategies are becoming more patient-focused
Please Note: This product is delivered as a zip file, which contains PDF and Power Point files.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008